Showing results (1531-1540 of 1,753) with videos related to
Sort By:
Pageof 176
Journal of Neurology|May 6, 2020
Exome sequencing in 38 patients with intracranial aneurysms and subarachnoid hemorrhageThomas Sauvigny, Malik Alawi, Linda Krause, et al.Elife|September 20, 2019
RIM-BP2 primes synaptic vesicles <i>via</i> recruitment of Munc13-1 at hippocampal mossy fiber synapsesMarisa M Brockmann, Marta Maglione, Claudia G Willmes, et al.Movement Disorders : Official Journal of the Movement Disorder Society|December 17, 2020
Soluble CD163 Changes Indicate Monocyte Association With Cognitive Deficits in Parkinson's DiseaseSara Konstantin Nissen, Sara Almeida Ferreira, Marlene Christina Nielsen, et al.Transplantation|May 14, 2010
Renal function, efficacy, and safety of sirolimus and mycophenolate mofetil after short-term calcineurin inhibitor-based quadruple therapy in de novo renal transplant patients: one-year analysis of a randomized multicenter trialMarkus Guba, Johann Pratschke, Christian Hugo, et al.Plos One|September 17, 2013
Evidence against a beneficial effect of irisin in humansSilja Raschke, Manuela Elsen, Hans Gassenhuber, et al.NPJ Parkinson'S Disease|April 14, 2026
Clinical correlates of a negative cerebrospinal fluid α-synuclein seed amplification assay result in Parkinson's diseaseAndrea Mastrangelo, Isabel Wurster, Alice Ticca, et al.Bioorganic Chemistry|July 7, 2020
8-Benzylaminoxanthine scaffold variations for selective ligands acting on adenosine A<sub>2A</sub> receptors. Design, synthesis and biological evaluationMichał Załuski, Jakub Schabikowski, Piotr Jaśko, et al.Journal of Neurology, Neurosurgery, and Psychiatry|May 24, 2023
Genotype-phenotype correlation and treatment effects in young patients with <i>GNAO1</i>-associated disordersMoritz Thiel, Daniel Bamborschke, Wibke G Janzarik, et al.Neurology|April 27, 2005
Cystic leukoencephalopathy without megalencephaly: a distinct disease entity in 15 childrenM Henneke, N Preuss, V Engelbrecht, et al.Scientific Reports|June 12, 2024
Elevated fecal calprotectin is associated with gut microbial dysbiosis, altered serum markers and clinical outcomes in older individualsSebastian Heinzel, Jenna Jureczek, Veera Kainulainen, et al.Pageof 176